The Invesco Perpetual UK Smaller Companies Equity Fund aims to achieve capital growth in the UK. The fund intends to invest primarily in shares of smaller companies in the UK. In pursuing this objective, the fund managers may include investments that they consider appropriate which include transferable securities, money market instruments, warrants, collective investment schemes, deposits and other permitted investments and transactions as detailed in Appendix 2 of the most recent Prospectus.
Name | % Net Assets |
---|---|
Synergy Healthcare | 3.4% |
Chemring | 2.5% |
Dechra Pharmaceuticals | 2.2% |
Diploma | 2.2% |
RPC | 2.0% |
Babcock International | 1.9% |
Elementis | 1.9% |
BTG | 1.8% |
RWS | 1.7% |
Paypoint | 1.6% |
Key | % Net Assets |
---|---|
Synergy Healthcare | 3.4% |
Chemring | 2.5% |
Dechra Pharmaceuticals | 2.2% |
Diploma | 2.2% |
Other | 89.7% |
Date | 21-Nov-2024 |
---|---|
NAV | 969.83p |
Currency | GBP |
Change | -14.80p |
% | -1.50% |
YTD change | -9.12p |
YTD % | -0.93% |
Fund Inception | 09/05/1992 |
---|---|
Fund Manager | Richard Smith |
TER | 1.70 (31-Dec-2013) |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | £100 |
Savings | £20 |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.67% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.23 |
You are here: research